Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 9,639 Cr.
- Current Price ₹ 1,885
- High / Low ₹ 2,449 / 1,508
- Stock P/E 50.8
- Book Value ₹ 105
- Dividend Yield 0.53 %
- ROCE 41.3 %
- ROE 41.4 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 33.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.6%
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Stock is trading at 17.9 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 197 | 214 | 236 | 288 | 366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | |
| 175 | 183 | 205 | 245 | 308 | 361 | 390 | 393 | 405 | 499 | 682 | 736 | |
| Operating Profit | 21 | 32 | 31 | 42 | 58 | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 
| OPM % | 11% | 15% | 13% | 15% | 16% | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 
| 6 | 6 | 2 | 3 | 1 | 2 | 2 | 3 | 3 | 4 | 6 | 26 | |
| Interest | 12 | 12 | 10 | 12 | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 
| Depreciation | 7 | 9 | 9 | 9 | 10 | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 
| Profit before tax | 8 | 18 | 14 | 24 | 36 | 65 | 67 | 73 | 75 | 97 | 133 | 246 | 
| Tax % | 33% | 28% | 24% | 27% | 33% | 33% | 32% | 31% | 31% | 32% | 35% | 18% | 
| 6 | 13 | 14 | 18 | 24 | 43 | 45 | 50 | 52 | 66 | 86 | 201 | |
| EPS in Rs | 1.10 | 2.51 | 2.74 | 3.45 | 4.75 | 8.48 | 8.85 | 9.81 | 10.16 | 12.94 | 16.88 | 39.47 | 
| Dividend Payout % | 36% | 24% | 22% | 23% | 21% | 19% | 18% | 41% | 20% | 22% | 19% | 20% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% | 
| 5 Years: | 16% | 
| 3 Years: | 26% | 
| TTM: | 17% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% | 
| 5 Years: | 33% | 
| 3 Years: | 54% | 
| TTM: | 120% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% | 
| 5 Years: | 10% | 
| 3 Years: | -14% | 
| 1 Year: | -10% | 
| Return on Equity | |
|---|---|
| 10 Years: | 28% | 
| 5 Years: | 29% | 
| 3 Years: | 32% | 
| Last Year: | 41% | 
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 
| Reserves | 56 | 64 | 75 | 88 | 106 | 140 | 174 | 199 | 246 | 299 | 369 | 526 | 
| 133 | 114 | 120 | 123 | 146 | 151 | 135 | 111 | 120 | 181 | 165 | 87 | |
| 54 | 51 | 52 | 60 | 78 | 98 | 93 | 95 | 147 | 159 | 218 | 160 | |
| Total Liabilities | 254 | 238 | 258 | 282 | 341 | 398 | 412 | 416 | 522 | 649 | 763 | 783 | 
| 103 | 98 | 98 | 122 | 126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 | |
| CWIP | 7 | 14 | 23 | 6 | 9 | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 
| Investments | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 13 | 16 | 0 | 
| 139 | 121 | 126 | 144 | 195 | 230 | 220 | 203 | 256 | 262 | 328 | 315 | |
| Total Assets | 254 | 238 | 258 | 282 | 341 | 398 | 412 | 416 | 522 | 649 | 763 | 783 | 
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 43 | 24 | 36 | 22 | 47 | 61 | 101 | 63 | 102 | 144 | 188 | |
| -22 | -10 | -17 | -19 | -27 | -27 | -31 | -35 | -65 | -132 | -67 | -41 | |
| 3 | -35 | -9 | -13 | 5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 | |
| Net Cash Flow | 3 | -2 | -2 | 4 | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 | 
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70 | 66 | 73 | 77 | 76 | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 
| Inventory Days | 261 | 180 | 166 | 124 | 132 | 126 | 105 | 92 | 165 | 99 | 88 | 67 | 
| Days Payable | 1 | 0 | 70 | 63 | 69 | 75 | 58 | 63 | 120 | 78 | 104 | 57 | 
| Cash Conversion Cycle | 329 | 246 | 170 | 137 | 139 | 124 | 123 | 96 | 116 | 94 | 51 | 71 | 
| Working Capital Days | 182 | 142 | 15 | 10 | 20 | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 
| ROCE % | 11% | 15% | 12% | 17% | 20% | 28% | 25% | 25% | 24% | 25% | 28% | 41% | 
Documents
Announcements
- 
        
          Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
          
            13 Oct - Board meeting on Nov 4, 2025 to approve unaudited results for quarter/half-year ended Sep 30, 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Oct
- Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Oct
- 
        
          General Updates - Launch Of 100 Days Campaign Titled 'Saksham Niveshak'
          
            4 Oct - Announces participation in IEPFA 'Saksham Niveshak' 100-day campaign to recover seven years' unclaimed dividends; contact MUFG Intime.
- 
        
          Closure of Trading Window
          
            25 Sep - Trading window closed from Oct 1, 2025 until 48 hours after unaudited results for quarter/half ending Sept 30, 2025.
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2012
      from bse
- 
    
      Financial Year 2011
      from nse
Concalls
- 
      May 2025TranscriptPPT
- 
      Nov 2024TranscriptPPT
- 
      May 2024Transcript PPT REC
- 
      May 2024TranscriptNotesPPTREC
- 
      Nov 2023TranscriptPPTREC
- 
      May 2023TranscriptPPT
- 
      Nov 2022TranscriptPPT
- 
      May 2022TranscriptPPT
- 
      Nov 2021TranscriptPPT
- 
      Jun 2021TranscriptPPT
- 
      Nov 2020TranscriptPPT
- 
      Jul 2020TranscriptPPT
- 
      Nov 2019TranscriptPPT
- 
      May 2019TranscriptPPT
- 
      Nov 2018TranscriptPPT
- 
      Jun 2018TranscriptPPT
- 
      Nov 2017TranscriptPPT
- 
      Jun 2017TranscriptPPT
- 
      May 2016TranscriptPPT
Business Leadership
The company is a leading manufacturer and global supplier of aliphatic amines, amine derivatives, and specialty chemicals. It offers over 100 products and is a global leader in several products, including synthetic Acetonitrile, DMAHCL, Triethylamine, Diethylhydroxylamine, and is the sole global producer of many specialty amines. [1]